Population-level distribution and putative immunogenicity of cancer neoepitopes

BACKGROUND: Tumor neoantigens are drivers of cancer immunotherapy response; however, current prediction tools produce many candidates requiring further prioritization. Additional filtration criteria and population-level understanding may assist with prioritization. Herein, we show neoepitope immunog...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Mary A., Paralkar, Mayur, Paralkar, Mihir P., Nguyen, Austin, Struck, Adam J., Ellrott, Kyle, Margolin, Adam, Nellore, Abhinav, Thompson, Reid F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899330/
https://www.ncbi.nlm.nih.gov/pubmed/29653567
http://dx.doi.org/10.1186/s12885-018-4325-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899330/
https://www.ncbi.nlm.nih.gov/pubmed/29653567
http://dx.doi.org/10.1186/s12885-018-4325-6

Ejemplares similares